Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax
Category : National Published on: September 04 2021
· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.
· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.
· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.
· This support will be provided from the preclinical phase to the third phase of the trial.
Important facts
About the DCGI
v DCGI: Drugs Controller General of India
v Headquarters location: New Delhi
R. Praggnanandhaa wins UzChess Cup Masters 2025 and becomes top-ranked Indian chess player.
Read More....Meesho gets shareholder approval to raise ₹4,250 crore via IPO after shifting domicile to India.
Read More....IPS officer Parag Jain appointed new RAW chief; played key role in Operation Sindoor.
Read More....ICC updates powerplay rules for shortened T20 matches effective from July 2025.
Read More....Power Ministry forms task force to develop 'India Energy Stack' for digital power infrastructure.
Read More....MNRE issues revised guidelines for Biomass Programme to promote clean energy adoption.
Read More....CBSE to hold Class 10 board exams twice a year from 2026 session; first phase mandatory, second optional.
Read More....NATO agrees to increase defence spending target to 5% of GDP by 2035 at The Hague summit.
Read More....India and South Africa sign agreements on submarine cooperation during defence talks.
Read More....Odisha wins women’s title in first Hockey India Masters Cup; Tamil Nadu enters men’s final.
Read More....